TRACON Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
SAN DIEGO, Nov. 10, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical…
SAN DIEGO, Nov. 10, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical…
Analysis of results from EMERGE™ Phase 3 efficacy trial of STS101 ongoing; expect to communicate…
– Updated clinical data from BIO89-100’s Phase 1b/2a NASH trial to be presented as a…
Dosing Initiated in CG-806 Phase 1 a/b Study in AML Patients at 450mg Dose Level…
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical…
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading…
REDWOOD CITY, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO),…
LAKE FOREST, Ill., Nov. 10, 2020 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”)…
Lumos Pharma has initiated Phase 2b OraGrowtH210 Trial evaluating oral LUM-201 in pediatric growth hormone…
SAN FRANCISCO, Nov. 10, 2020 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage…
FDA confirms that a single Phase III clinical trial may be adequate for submitting U.S….
Company Announcement Copenhagen, Denmark; November 10, 2020 – Genmab A/S (Nasdaq: GMAB) will increase its…
DURHAM, N.C., Nov. 10, 2020 (GLOBE NEWSWIRE) — CoImmune, Inc., an immuno-oncology company developing cell-based…
PRESS RELEASE November 10, 2020 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on…
Saint-Herblain (France), November 10, 2020 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine…
Introducing tearcheck – A new standard for dry eye analysis The tearcheck in action –…
FARMINGTON HILLS, Mich., Nov. 10, 2020 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc., a clinical-stage ophthalmic…
ROCKVILLE, Md., Nov. 10, 2020 (GLOBE NEWSWIRE) — American Gene Technologies (AGT) announced today that…
Enhanced, feature-rich telematics device offers multi-network connectivity and a flexible programming environment to develop custom…
Enhanced, feature-rich telematics device offers multi-network connectivity and a flexible programming environment to develop custom…